Arabinosyl cytosine palmitate—also called cytarabine palmitate or palmitoyl cytarabine—is a lipophilic prodrug of cytarabine (Ara‑C), a chemotherapy agent. The palmitate ester modification enhances its properties for slow, sustained release and better delivery, particularly in cancer treatment. The directory classifies it as a discontinued API with a semi-synthetic source/manufacturing origin. Other names for this substance include Palmitoyl cytarabine and Aracytidine 5′-palmitate. Its PubChem CID is 35731.
Arabinosyl cytosine palmitate
| CAS No | 31088-06-9 |
|---|---|
| Molecular Formula | C25H43N3O6 |
| Molecular Weight | 481.6 g/mol |
| Synonyms | [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Arabinosyl cytosine palmitate—also called cytarabine palmitate or palmitoyl cytarabine—is a lipophilic prodrug of cytarabine (Ara‑C), a chemotherapy agent. The palmitate ester modification enhances its properties for slow, sustained release and better delivery, particularly in cancer treatment.
The listed CAS number is 31088-06-9.
The listed molecular formula is C25H43N3O6.
The listed molecular weight is 481.6 g/mol.
[(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate.
The source lists Palmitoyl cytarabine and Aracytidine 5'-palmitate.